Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial”

Duk-Woo Park; Seung-Jung Park

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial”

【24h】

Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial”

机译：公园和公园对文章的回应，“临床显着出血与韩国急性冠状动脉综合征患者的TicagreloLoR与氯吡格雷用于侵入性管理：随机临床试验”

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2020年第14期|共2页
作者
Duk-Woo Park; Seung-Jung Park;
展开▼
作者单位

Department of Cardiology Asan Medical Center University of Ulsan College of Medicine;

Department of Cardiology Asan Medical Center University of Ulsan College of Medicine;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial” [J] . Duk-Woo Park, Seung-Jung Park Circulation: An Official Journal of the American Heart Association . 2020,第14期

机译：公园和公园对文章的回应，“临床显着出血与韩国急性冠状动脉综合征患者的TicagreloLoR与氯吡格雷用于侵入性管理：随机临床试验”
2. Letter by Kim et al Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial” [J] . Yongcheol Kim, Thomas W. Johnson, Myung Ho Jeong Circulation: An Official Journal of the American Heart Association . 2020,第14期

机译：Kim等人对文章的信，“韩国患者的TiCagreloROR与氯吡格雷患者临床显着的出血，用于侵入性管理的急性冠状动脉综合征：随机临床试验”
3. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management A Randomized Clinical Trial [J] . Park Duk-Woo, Kwon Osung, Jang Jae-Sik, Circulation: An Official Journal of the American Heart Association . 2019,第23期

机译：临床上与韩国患者的临床显着的出血，韩国患者急性冠状动脉综合征旨在进行侵入式临床试验
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. The effect of a fear -avoidance based intervention for patients with acute low back pain. A randomized clinical trial [D] . George, Steven Zachary 2002

机译：基于恐惧回避的干预对急性下腰痛患者的影响。一项随机临床试验
6. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial [O] . Stefan K James, Matthew T Roe, Christopher P Cannon, 2011

机译：替卡格雷与氯吡格雷在急性冠脉综合征患者中的非侵入性治疗：前瞻性随机PLATelet抑制和患者结果（PLATO）试验的子研究
7. Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial” [O] . Duk-Woo Park, Seung-Jung Park 2020

机译：公园和公园对文章的回应，“韩国冠心病患者临床显着出血，韩国患者患者侵入性管理：随机临床试验”

Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial”

著录项

相似文献

相关主题

期刊订阅